Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heron Therapeutics (NQ: HRTX )

1.820 -0.090 (-4.71%)
Streaming Delayed Price Updated: 12:34 PM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 785,271
Open 1.870
Bid (Size) 1.820 (22)
Ask (Size) 1.830 (69)
Prev. Close 1.910
Today's Range 1.810 - 1.935
52wk Range 1.800 - 6.375
Shares Outstanding 118,888,122
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. 
Via Benzinga
Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this... 
Via Benzinga

Performance

YTD
-25.10%
-25.10%
1 Month
-20.18%
-20.18%
3 Month
-22.55%
-22.55%
6 Month
-52.85%
-52.85%
1 Year
-67.15%
-67.15%

More News

Read More
Heron Therapeutics's Earnings Outlook
Via Benzinga
Analysts Cut Price Targets As Heron Therapeutics' Zynrelef Disappoints In Q3
Via Benzinga
FDA Approves Heron Therapeutics' Post-Op Nausea Treatment
Via Benzinga
Heron Shares Jump After Equity Financing, Q2 Earnings
Via Benzinga
Earnings Scheduled For March 23, 2023
Via Benzinga
Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Heron Therapeutics Files For Expanded Use Of Zynrelef In Soft Tissue, Orthopedic Surgical Procedures
Via Benzinga
7 Penny Stocks to Buy for 10-Bagger Returns
Via InvestorPlace
Earnings Outlook For Heron Therapeutics
Via Benzinga
Hurry! 7 Pitiful Stocks to Sell Before 2022 Ends
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
4 No-Brainer Penny Stocks to Buy if You Have Money to Invest
Via InvestorPlace
7 Unknown Biotech Stocks That Could Rocket in 2023
Via InvestorPlace
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Via Benzinga
Earnings Outlook For Heron Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
7 Biotech Stocks to Buy for Q3
Via InvestorPlace
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
80 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.